EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer

被引：0
|
作者：
Giuseppe Giaccone
机构：
[1] Head of the Department of Medical Oncology of the Free University Medical Center,
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：296 / 297
页数：1
相关论文
共 50 条
  • [1] EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer
    Giaccone, G
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 296 - 297
  • [2] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [3] EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer
    Shih, JY
    Gow, CH
    Yang, PC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 207 - 208
  • [4] Activity of Gefitinib in a Non-Small-Cell Lung Cancer Patient with Both Activating and Resistance EGFR Mutations
    Morabito, Alessandro
    Costanzo, Raffaele
    Rachiglio, Anna Maria
    Pasquale, Raffaella
    Sandomenico, Claudia
    Franco, Renato
    Montanino, Agnese
    De Lutio, Elisabetta
    Rocco, Gaetano
    Normanno, Nicola
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : E59 - E60
  • [5] Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer
    Tokumo, Masaki
    Toyookaa, Shinichi
    Ichihara, Shuji
    Ohashi, Kadoaki
    Tsukuda, Kazunori
    Ichimura, Kouichi
    Tabata, Masahiro
    Kiura, Katsuyuki
    Aoe, Motoi
    Sano, Yoshifumi
    Date, Hiroshi
    Shimizu, Nobuyoshi
    [J]. LUNG CANCER, 2006, 53 (01) : 117 - 121
  • [6] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [7] EGFR mutation analysis in non-small-cell lung cancer
    Tapia, C.
    Savic, S.
    Bihl, M.
    Rufle, A.
    Zlobec, I.
    Terracciano, L.
    Bubendorf, L.
    [J]. PATHOLOGE, 2009, 30 (05): : 384 - 392
  • [8] Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
    Maemondo, Makoto
    Inoue, Akira
    Kobayashi, Kunihiko
    Sugawara, Shunichi
    Oizumi, Satoshi
    Isobe, Hiroshi
    Gemma, Akihiko
    Harada, Masao
    Yoshizawa, Hirohisa
    Kinoshita, Ichiro
    Fujita, Yuka
    Okinaga, Shoji
    Hirano, Haruto
    Yoshimori, Kozo
    Harada, Toshiyuki
    Ogura, Takashi
    Ando, Masahiro
    Miyazawa, Hitoshi
    Tanaka, Tomoaki
    Saijo, Yasuo
    Hagiwara, Koichi
    Morita, Satoshi
    Nukiwa, Toshihiro
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2380 - 2388
  • [9] Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Knez, Lea
    Stanic, Karmen
    Zwitter, Matjaz
    Cufer, Tanja
    [J]. CLINICAL LUNG CANCER, 2017, 18 (03) : E187 - E196
  • [10] Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment
    Jida, Masaru
    Toyooka, Shinichi
    Mitsudomi, Tetsuya
    Takano, Toshimi
    Matsuo, Keitaro
    Hotta, Katsuyuki
    Tsukuda, Kazunori
    Kubo, Takafumi
    Yamamoto, Hiromasa
    Yamane, Masaomi
    Oto, Takahiro
    Sano, Yoshifumi
    Kiura, Katsuyuki
    Yatabe, Yasushi
    Ohe, Yuichiro
    Date, Hiroshi
    Miyoshi, Shinichiro
    [J]. CANCER SCIENCE, 2009, 100 (10): : 1931 - 1934
12345